These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1400919)

  • 1. Longitudinal sensitivity of the Fuld cholinergic profile to Alzheimer's disease.
    Goldman RS; Axelrod BN; Giordani BJ; Foster N; Berent S
    J Clin Exp Neuropsychol; 1992 Jul; 14(4):566-74. PubMed ID: 1400919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wechsler Intelligence Scale profiles, the cholinergic system, and Alzheimer's disease.
    Filley CM; Kobayashi J; Heaton RK
    J Clin Exp Neuropsychol; 1987 Apr; 9(2):180-6. PubMed ID: 3558750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WAIS-R subtest profile and cortical perfusion in Alzheimer's disease.
    Alexander GE; Prohovnik I; Stern Y; Mayeux R
    Brain Cogn; 1994 Jan; 24(1):24-43. PubMed ID: 8123262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the diagnostic utility of the Fuld cholinergic deficit profile on the Japanese WAIS-R.
    Yamashita H; Hirono N; Ikeda M; Ikejiri Y; Imamura T; Shimomura T; Mori E
    J Clin Exp Neuropsychol; 1997 Apr; 19(2):300-4. PubMed ID: 9240488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The WAIS-R profile as a cognitive marker of Alzheimer's disease: a misguided venture?
    Gfeller JD; Rankin EJ
    J Clin Exp Neuropsychol; 1991 Jul; 13(4):629-36. PubMed ID: 1918292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central cholinergic deficiency WAIS profiles in a nondemented aged sample.
    Tuokko H; Crockett D
    J Clin Exp Neuropsychol; 1987 Apr; 9(2):225-7. PubMed ID: 3558752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validity of the Japanese version of Rivermead Behavioural Memory Test for evaluation of everyday memory function in patients with mild Alzheimer's disease].
    Matsuda A; Kazui H; Hirono N; Mori E
    No To Shinkei; 2002 Aug; 54(8):673-8. PubMed ID: 12355878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The profile of memory disturbance in early Lewy body dementia differs from that in Alzheimer's disease].
    Mormont E; Laurier-Grymonprez L; Baisset-Mouly C; Pasquier F
    Rev Neurol (Paris); 2003 Sep; 159(8-9):762-6. PubMed ID: 13679718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of the WAIS-R Fuld profile in HIV-1 infection.
    van Gorp WG; Tulin SJ; Evans G; Satz P
    J Clin Exp Neuropsychol; 1990 Oct; 12(5):807-11. PubMed ID: 2258439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The WAIS-R profile: a diagnostic tool for Alzheimer's disease?
    Logsdon RG; Teri L; Williams DE; Vitiello MV; Prinz PN
    J Clin Exp Neuropsychol; 1989 Dec; 11(6):892-8. PubMed ID: 2592529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A WAIS-R marker for accelerated aging and dementia, Alzheimer's type? Base rates of the Fuld formula in the WAIS-R standardization sample.
    Satz P; Hynd GW; D'Elia L; Daniel MH; Van Gorp W; Connor R
    J Clin Exp Neuropsychol; 1990 Oct; 12(5):759-65. PubMed ID: 2258435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory deficits in patients with schizophrenia: preliminary data from the Wechsler Memory Scale-Third Edition support earlier findings.
    Hawkins KA
    J Psychiatry Neurosci; 1999 Sep; 24(4):341-7. PubMed ID: 10516802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neural correlates of verbal short-term memory in Alzheimer's disease: an fMRI study.
    Peters F; Collette F; Degueldre C; Sterpenich V; Majerus S; Salmon E
    Brain; 2009 Jul; 132(Pt 7):1833-46. PubMed ID: 19433442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WAIS-R marker for dementia of the Alzheimer type? An empirical and statistical induction test.
    Satz P; Van Gorp WG; Soper HV; Mitrushina M
    J Clin Exp Neuropsychol; 1987 Dec; 9(6):767-74. PubMed ID: 3693533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.
    Brodaty H; Moore CM
    Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory for new information as a cognitive marker of liability to Alzheimer's disease in a high risk group: a research note.
    Rice F; Abraham R; Rudrasingham V; Owen MJ; Williams J
    Int J Geriatr Psychiatry; 2003 Feb; 18(2):155-60. PubMed ID: 12571825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity.
    Sämgård K; Zetterberg H; Blennow K; Hansson O; Minthon L; Londos E
    Int J Geriatr Psychiatry; 2010 Apr; 25(4):403-10. PubMed ID: 19650161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuropsychological profile in dementia with Lewy bodies and Alzheimer's disease.
    Oda H; Yamamoto Y; Maeda K
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):125-31. PubMed ID: 18615776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Working memory and secondary memory deficits in Alzheimer's disease.
    Becker JT
    J Clin Exp Neuropsychol; 1988 Dec; 10(6):739-53. PubMed ID: 3235648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provoked confabulations in Alzheimer's disease.
    Cooper JM; Shanks MF; Venneri A
    Neuropsychologia; 2006; 44(10):1697-707. PubMed ID: 16697019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.